Orally administered amphotericin B in the treatment of oral candidiasis in HIV-infected patients caused by azole-resistant Candida albicans.
Nguyen
M T
MT
Weiss
P J
PJ
LaBarre
R C
RC
Miller
L K
LK
Oldfield
E C
EC
Wallace
M R
MR
D017088:AIDS-Related Opportunistic Infections; D000284:Administration, Oral; D000666:Amphotericin B / Q000008:administration & dosage* / Q000494:pharmacology; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000494:pharmacology; D002177:Candidiasis / Q000188:drug therapy* / Q000209:etiology; D004352:Drug Resistance, Microbial; D015658:HIV Infections / Q000150:complications*; D015497:HIV-1; D006801:Humans; D009055:Mouth / Q000382:microbiology
D000935:Antifungal Agents; D000666:Amphotericin B